Gilpin Wealth Management’s Innoviva INVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$191 Sell
9
-6
-40% -$127 ﹤0.01% 1133
2026
Q2
$341 Buy
15
+4
+36% +$92 ﹤0.01% 788
2026
Q1
$257 Buy
11
+5
+83% +$108 ﹤0.01% 798
2025
Q4
$120 Buy
+6
New +$117 ﹤0.01% 791

Other funds holding INVA

Gilpin Wealth Management's INVA Position: Q3 2026 in Review

Gilpin Wealth Management reduced its Innoviva (INVA) stake by 40% in Q3 2026, selling an estimated $127 and leaving 9 shares worth $191. The position accounts for ﹤0.01% of the portfolio, ranked #1133.

Gilpin Wealth Management first reported a position in INVA in Q4 2025 and has held it in 4 quarters since. The position peaked at $341 in Q2 2026. 7 funds tracked by Wall St. Rank hold INVA as of Q3 2026.

  • Gilpin Wealth Management held 9 shares of Innoviva worth $191 as of Q3 2026.
  • Gilpin Wealth Management sold 6 Innoviva shares in Q3 2026, an estimated $127.
  • Innoviva made up ﹤0.01% of Gilpin Wealth Management's portfolio in Q3 2026, its #1133 holding.
  • Gilpin Wealth Management first reported a position in Innoviva in Q4 2025 and has held it in 4 quarters since.
  • Gilpin Wealth Management's Innoviva position peaked at $341 in Q2 2026.
  • 7 funds tracked by Wall St. Rank held Innoviva as of Q3 2026.

Based on Gilpin Wealth Management's 13F filing for Q3 2026, filed 9 Oct 2026.